Viewing Study NCT03391193


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-20 @ 6:35 PM
Study NCT ID: NCT03391193
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2017-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module